{"title":"Akkermansia muciniphila 和草药在免疫相关疾病中的应用:现有证据和未来展望","authors":"Xue Ding, Pengfei Meng, Xiu-xia Ma, Jing-Yu Yue, Liang-Ping Li, Li-Ran Xu","doi":"10.3389/frmbi.2024.1276015","DOIUrl":null,"url":null,"abstract":"Akkermansia muciniphila is considered the “paradigm for next-generation beneficial microorganisms” and has been reported to help alleviat immune-related diseases. Evidence shows that herbal medicine can treat disease by regulating the abundance of A. muciniphila. Recent studies have revealed a link between A. muciniphila and immune-related diseases. Here, we systematically reviewed the association between A. muciniphila, herbal medicine, and immune-related diseases (including inflammatory bowel disease, human immunodeficiency virus, cancer immunotherapy, and immune-related liver injury). We also summarize the potential mechanisms of action of A. muciniphila and offer perspectives for future studies.","PeriodicalId":73089,"journal":{"name":"Frontiers in microbiomes","volume":"27 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Akkermansia muciniphila and herbal medicine in immune-related diseases: current evidence and future perspectives\",\"authors\":\"Xue Ding, Pengfei Meng, Xiu-xia Ma, Jing-Yu Yue, Liang-Ping Li, Li-Ran Xu\",\"doi\":\"10.3389/frmbi.2024.1276015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Akkermansia muciniphila is considered the “paradigm for next-generation beneficial microorganisms” and has been reported to help alleviat immune-related diseases. Evidence shows that herbal medicine can treat disease by regulating the abundance of A. muciniphila. Recent studies have revealed a link between A. muciniphila and immune-related diseases. Here, we systematically reviewed the association between A. muciniphila, herbal medicine, and immune-related diseases (including inflammatory bowel disease, human immunodeficiency virus, cancer immunotherapy, and immune-related liver injury). We also summarize the potential mechanisms of action of A. muciniphila and offer perspectives for future studies.\",\"PeriodicalId\":73089,\"journal\":{\"name\":\"Frontiers in microbiomes\",\"volume\":\"27 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in microbiomes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/frmbi.2024.1276015\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in microbiomes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/frmbi.2024.1276015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
Akkermansia muciniphila 被认为是 "下一代有益微生物的典范",据报道有助于缓解与免疫有关的疾病。有证据表明,中草药可以通过调节粘液虹彩菌的数量来治疗疾病。最近的研究揭示了粘菌与免疫相关疾病之间的联系。在此,我们系统回顾了粘菌素、中药和免疫相关疾病(包括炎症性肠病、人类免疫缺陷病毒、癌症免疫治疗和免疫相关肝损伤)之间的联系。我们还总结了 A. muciniphila 的潜在作用机制,并为未来的研究提供了展望。
Akkermansia muciniphila and herbal medicine in immune-related diseases: current evidence and future perspectives
Akkermansia muciniphila is considered the “paradigm for next-generation beneficial microorganisms” and has been reported to help alleviat immune-related diseases. Evidence shows that herbal medicine can treat disease by regulating the abundance of A. muciniphila. Recent studies have revealed a link between A. muciniphila and immune-related diseases. Here, we systematically reviewed the association between A. muciniphila, herbal medicine, and immune-related diseases (including inflammatory bowel disease, human immunodeficiency virus, cancer immunotherapy, and immune-related liver injury). We also summarize the potential mechanisms of action of A. muciniphila and offer perspectives for future studies.